TCL Archive The shadow of Iressa lingered over the FDA Oncologic Drugs Advisory Committee as the panel voted down Genasense (Genta Inc.) and RSR13 (Allos Therapeutics Inc.) at its May 3 meeting. If anyone thought the bar had been lowered for drug approvals, they were mistaken. May 7, 2004
TCL Archive Study: Rencarex Treatment Efficacy Increases With CAIX Antigen Density in Tumor Tissue March 29, 2013
TCL Archive In Brief: Rosenthal Names ACS President; Brown, Lynch, Mintz Win ACS Medals of Honor November 14, 1997
